Atherectomy Systems Market

Atherectomy Systems Market (Product Type: Directional Atherectomy Devices, Rotational Atherectomy, Orbital Atherectomy Devices, Laser Atherectomy Devices, Image-guided Atherectomy Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Atherectomy Systems Market Outlook 2031

  • The industry was valued at US$ 621.8 Mn in 2021
  • It is projected to grow at a CAGR of 6.0% from 2022 to 2031 and reach more than US$ 1.1 Bn by the end of 2031

Analysts’ Viewpoint

Rise in prevalence of peripheral and coronary artery diseases is expected to propel the global atherectomy systems industry growth during the forecast period. Atherectomy is a minimally invasive procedure used to remove plaque buildup from arteries in the body, thereby improving blood flow and reducing the risk of heart attacks or strokes.

Increase in incidence of cardiovascular diseases and rise in awareness about efficient atherectomy treatment are expected to augment market progress in the near future. Leading companies in the global market are focusing on R&D activities to develop new diagnostic technologies. This is likely to offer lucrative growth opportunities for vendors in the industry. Key players are launching advanced medical devices in order to increase their atherectomy systems market share.

Atherectomy Systems Market

Atherectomy Systems Market Overview

Atherectomy systems are medical devices used to remove plaque buildup from the inner walls of arteries to improve blood flow. These systems use various techniques such as laser, ultrasound, or rotational ablation to remove plaque and improve blood flow to the heart, brain, and other vital organs.

Rise in Prevalence of Cardiovascular Diseases

Rapidly rise in incidence of cardiovascular diseases is one of the key drivers of the atherectomy systems market growth. Cardiovascular diseases, also known as heart diseases, are a group of conditions that affect the heart and blood vessels. These conditions are the leading cause of death, globally, and are a major public health concern. Increase in prevalence of cardiovascular diseases is majorly due to factors such as unhealthy lifestyles, sedentary jobs, unhealthy diet, and stress.

According to the World Health Organization (WHO), cardiovascular diseases are responsible for over 17 million deaths annually, accounting for 31.0% of all global deaths. Incidence of cardiovascular diseases is expected to increase in the next few years, owing to the significant rise in global aging population. Furthermore, rise in prevalence of chronic conditions, such as high blood pressure, high cholesterol levels, and obesity, is further contributing to the atherectomy systems market development.

Increase in Demand for Minimally Invasive Procedures

Patients are more likely to opt for pain-free minimally invasive procedures that make a smaller incision into the body. Atherectomy procedure is a minimally invasive medical procedure that involves removing plaque or blockages in blood vessels to improve blood flow. It offers several advantages over traditional open surgeries, including faster recovery time, reduced pain, and lower risk of complications.

Minimally invasive procedures are often associated with better patient outcomes, including improved function and appearance. These procedures are less expensive than traditional open surgeries, making them more accessible to a wider patient population. All these factors are projected to fuel global atherectomy systems market size in the near future.

Surge in Demand for Directional Atherectomy Devices

In terms of product type, the directional atherectomy devices segment held major share of the global market in 2021. Increase in prevalence of cardiovascular diseases is likely to drive the segment. Directional atherectomy devices utilize rotating or oscillating blades, laser, or ultrasound energy to remove plaque from the vessel walls. These devices are commonly used in the treatment of peripheral artery diseases.

Increase in Preference for Hospitals to Perform Atherectomy Procedures

Based on end-user, the hospitals segment is likely to lead the global market during the forecast period. Rise in geriatric population suffering from severe chronic disorders, improvement in healthcare infrastructure in various regions, and increase in availability of advanced treatments in hospitals are major factors boosting the segment.

Additionally, advancements in medical technology and emergence of new medical devices have significantly improved patient outcomes. Healthcare services in hospitals are more accessible and convenient for patients. Hence, rise in demand for healthcare services has led to an increase in number of hospitals offering specialized services for patients.

Regional Outlook of Global Atherectomy Systems Industry

North America is expected to be a highly lucrative market during the forecast period. This region held 30.0% share of the global industry in 2021. The atherectomy systems market share held by North America is likely to increase in the near future, owing to the rise in incidence of cardiovascular diseases in the region. The U.S. is projected to dominate the North America market due to the significant presence of major market players in the country along with increase in research and development activities in the field of atherectomy.

The market in Asia Pacific is projected to grow at the highest CAGR during the forecast period, due to the high incidence rate of cardiovascular diseases in the region.

Analysis of Key Players

The global market is fragmented, with the presence of large numbers of key players. According to the atherectomy systems market research report, key players are investing in research & development projects, primarily to develop innovative tests such as rapid tests. These players are gaining lucrative atherectomy systems market opportunities by implementing various strategies including expansion of product portfolio and mergers & acquisitions.

As per the atherectomy industry research report, key players in the global market are Abbott Laboratories, B. Braun SE, Boston Scientific Corporation, Becton, Dickinson and Company, Cardinal Health Inc, Koninklijke Philips N.V., Medtronic, RA Medical Systems, and Terumo Corporation.

Key Developments in Global Atherectomy Systems Business

  • In October 2022, Cardiovascular Systems, Inc., a major medical device company that develops innovative interventional treatment systems for patients with peripheral and coronary artery disease, launched 2.00 Max Crown for peripheral orbital atherectomy systems. This device is built on the tried-and-true Diamondback 360® orbital atherectomy platform.
  • In August 2022, AngioDynamics, Inc. announced that it received 510(k) clearance of an expanded indication for the Auryon Atherectomy System to incorporate arterial thrombectomy.

Key players have been profiled in the atherectomy systems market forecast report based on parameters such as product portfolio, business segments, recent developments, company overview, and business strategies.

Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 621.8 Mn

Market Forecast Value in 2031

More than US$ 1.1 Bn

Growth Rate (CAGR)

6.0%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn/Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Directional Atherectomy Devices
    • Rotational Atherectomy Devices
    • Orbital Atherectomy Devices
    • Laser Atherectomy Devices
    • Image-guided Atherectomy Devices
  • Application
    • Cardiovascular Diseases
    • Peripheral Artery Diseases
    • Neurovascular Diseases
  • End-user
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers & Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand

Companies Profiled

  • Abbott Laboratories
  • B. Braun SE
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Cardinal Health Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • RA Medical Systems
  • Terumo Corporation
  • Other Prominent Players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global atherectomy systems market in 2021?

The global market was valued at US$ 621.8 Mn in 2021

How big will it be in 2031?

It is projected to reach a value of more than US$ 1.1 Bn by 2031

What will be the CAGR during the forecast period (2022–2031)?

It is anticipated to grow at a CAGR of 6.0% from 2022 to 2031

Which are the prominent trends that affect industry growth?

Rise in prevalence of cardiovascular diseases and increase in demand for minimally invasive procedures

Which region is expected to account for major share during the forecast period?

North America is likely to account for major share during the forecast period

Who are the prominent players in the business?

Abbott Laboratories, B. Braun SE, Boston Scientific Corporation, Becton, Dickinson and Company, Cardinal Health Inc, Koninklijke Philips N.V., Medtronic, RA Medical Systems, and Terumo Corporation

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Atherectomy Systems Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Atherectomy Systems Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Technological Advancements

        5.2. Regulatory Scenario by Region/Globally

        5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

    6. Global Atherectomy Systems Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Directional Atherectomy Devices

            6.3.2. Rotational Atherectomy Devices

            6.3.3. Orbital Atherectomy Devices

            6.3.4. Laser Atherectomy Devices

            6.3.5. Image-guided Atherectomy Devices

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Atherectomy Systems Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Cardiovascular Diseases

            7.3.2. Peripheral Artery Diseases

            7.3.3. Neurovascular Diseases

        7.4. Market Attractiveness Analysis, by Application

    8. Global Atherectomy Systems Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Specialty Clinics

            8.3.3. Ambulatory surgical centers & Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Atherectomy Systems Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Atherectomy Systems Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2031

            10.2.1. Directional Atherectomy Devices

            10.2.2. Rotational Atherectomy Devices

            10.2.3. Orbital Atherectomy Devices

            10.2.4. Laser Atherectomy Devices

            10.2.5. Image-guided Atherectomy Devices

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Cardiovascular Diseases

            10.3.2. Peripheral Artery Diseases

            10.3.3. Neurovascular Diseases

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Specialty Clinics

            10.4.3. Ambulatory surgical centers & Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Atherectomy Systems Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Directional Atherectomy Devices

            11.2.2. Rotational Atherectomy Devices

            11.2.3. Orbital Atherectomy Devices

            11.2.4. Laser Atherectomy Devices

            11.2.5. Image-guided Atherectomy Devices

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Cardiovascular Diseases

            11.3.2. Peripheral Artery Diseases

            11.3.3. Neurovascular Diseases

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Specialty Clinics

            11.4.3. Ambulatory surgical centers & Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Atherectomy Systems Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Directional Atherectomy Devices

            12.2.2. Rotational Atherectomy Devices

            12.2.3. Orbital Atherectomy Devices

            12.2.4. Laser Atherectomy Devices

            12.2.5. Image-guided Atherectomy Devices

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Cardiovascular Diseases

            12.3.2. Peripheral Artery Diseases

            12.3.3. Neurovascular Diseases

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Specialty Clinics

            12.4.3. Ambulatory Surgical Centres & Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Atherectomy Systems Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Directional Atherectomy Devices

            13.2.2. Rotational Atherectomy Devices

            13.2.3. Orbital Atherectomy Devices

            13.2.4. Laser Atherectomy Devices

            13.2.5. Image-guided Atherectomy Devices

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Cardiovascular Diseases

            13.3.2. Peripheral Artery Diseases

            13.3.3. Neurovascular Diseases

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Specialty Clinics

            13.4.3. Ambulatory Surgical Centres & Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Atherectomy Systems Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Directional Atherectomy Devices

            14.2.2. Rotational Atherectomy Devices

            14.2.3. Orbital Atherectomy Devices

            14.2.4. Laser Atherectomy Devices

            14.2.5. Image-guided Atherectomy Devices

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Cardiovascular Diseases

            14.3.2. Peripheral Artery Diseases

            14.3.3. Neurovascular Diseases

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals

            14.4.2. Specialty Clinics

            14.4.3. Ambulatory Surgical Centres & Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company (2021)

        15.3. Company Profiles

            15.3.1. Abbott Laboratories.

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Type Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. B. Braun SE

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Type Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Boston Scientific Corporation

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Type Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. Becton, Dickinson and Company

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Type Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. Cardinal Health Inc.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Type Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

            15.3.6. Koninklijke Philips N.V.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Type Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

            15.3.7. Medtronic

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Product Type Portfolio

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

            15.3.8. RA Medical Systems

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Product Type Portfolio

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

            15.3.9. Terumo Corporation

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Product Type Portfolio

                15.3.9.3. Financial Overview

                15.3.9.4. SWOT Analysis

    List of Tables

    Table 01: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 07: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 11: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 15: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Atherectomy Systems Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Atherectomy Systems Market Value Share, by Product Type (2021)

    Figure 03: Global Atherectomy Systems Market Value Share, by End-user (2021)

    Figure 04: Global Atherectomy Systems Market Value Share, by Application (2021)

    Figure 05: Global Atherectomy Systems Market Value Share, by Region (2021)

    Figure 06: Global Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 07: Global Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031

    Figure 08: Global Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031

    Figure 09: Global Atherectomy Systems Market Attractiveness, by Application, 2022–2031

    Figure 10: Global Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 11: Global Atherectomy Systems Market Attractiveness, by End-user, 2022–2031

    Figure 12: Global Atherectomy Systems Market Value Share Analysis, by Region, 2021 and 2031

    Figure 13: Global Atherectomy Systems Market Attractiveness, by Region, 2022-2031

    Figure 14: North America Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 15: North America Atherectomy Systems Market Value Share (%), by Country, 2021 and 2031

    Figure 16: North America Atherectomy Systems Market Attractiveness, by Country, 2022–2031

    Figure 17: North America Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 18: North America Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031

    Figure 19: North America Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031

    Figure 20: North America Atherectomy Systems Market Attractiveness, by Application, 2022–2031

    Figure 21: North America Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 22: North America Atherectomy Systems Market Attractiveness, by End-user, 2022–2031

    Figure 23: Europe Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 24: Europe Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 25: Europe Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031

    Figure 26: Europe Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 27: Europe Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031

    Figure 28: Europe Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031

    Figure 29: Europe Atherectomy Systems Market Attractiveness, by Application, 2022–2031

    Figure 30: Europe Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 31: Europe Atherectomy Systems Market Attractiveness, by End-user, 2022–2031

    Figure 32: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 33: Asia Pacific Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 34: Asia Pacific Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031

    Figure 35: Asia Pacific Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 36: Asia Pacific Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031

    Figure 37: Asia Pacific Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031

    Figure 38: Asia Pacific Atherectomy Systems Market Attractiveness, by Application, 2022–2031

    Figure 39: Asia Pacific Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 40: Asia Pacific Atherectomy Systems Market Attractiveness, by End-user, 2022–2031

    Figure 41: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 42: Latin America Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031 

    Figure 43: Latin America Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031

    Figure 44: Latin America Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031 

    Figure 45: Latin America Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031

    Figure 46: Latin America Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031 

    Figure 47: Latin America Atherectomy Systems Market Attractiveness, by Application, 2022–2031

    Figure 48: Latin America Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 49: Latin America Atherectomy Systems Market Attractiveness, by End-user, 2022–2031

    Figure 50: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 51: Middle East & Africa Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 52: Middle East & Africa Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031

    Figure 53: Middle East & Africa Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031

    Figure 54: Middle East & Africa Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031

    Figure 55: Middle East & Africa Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031

    Figure 56: Middle East & Africa Atherectomy Systems Market Attractiveness, by Application, 2022–2031

    Figure 57: Middle East & Africa Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 58: Middle East & Africa Atherectomy Systems Market Attractiveness, by End-user, 2022–2031

    Figure 59: Global Atherectomy Systems Market Share Analysis, by Company, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved